We narrowed to 350 results for: GAI;

...multiplicity of infection (MOI=ratio of virus to cells). Again, my tip here is to test several protocols as the...

...DNA ligase, are naturally able to discriminate against ligating substrates containing base pair mismatches...

...and Red (ReNL; plasmid #85203) NLuc fusions. The Nagai lab has additionally deposited more than 25 fusions...

...signal in these assays (Dempster et al., 2019). Again, the experimental strategy is clear: for any gene...

...modifications, and other factors that AAV utilizes to gain entry into the cell (Dudek, AM. 2018).  If the serotype...

...mutagenesis screens that detect loss-of-function or gain-of-function mutations. In these screens, the transposons...

...temperature allows the repressor to re-nature and again repress expression of exo, beta and gam.  A major...

...lymphocytes from the bone marrow to the thymus where they gain their specificity or from the thymus to the lymph...

...complexes - from the cell-lysate using antibodies against the target protein. The captured protein complexes...

...briefly go through each section of this article again. In the beginning, we talked about the relationship...

...principles of this classification system will help you gain a deeper appreciation and understanding of CRISPR...

...in any NIH grant application! Using FRET, you may gain a new structural understanding of your protein that...

...for sufficient opsin to reach the axon terminal. Again, this must be empirically determined in your own...

...precise location. The end of the heteroduplex rests against the RuvC nuclease domain, which stabilizes the ...

...olanzapine has also been shown to be an agonist against hM4Di, and is especially attractive for use in .../doi.org/10.1126/science.aav5282 PMID: 30872534 Nagai, Y., Miyakawa, N., Takuwa, H., Hori, Y., Oyama, ...

...pick one or the other. Which prime editor is which again? We’re glad you asked. Hopefully this table helps...

...deaminases at atomic resolution PE6d: Processivity gains and overextension trade-offs The prime editor PE6d...

...succeed. With respect to de novo sgRNA design, I again separate it into two categories. On the one hand...

...used to protect the RNAs from cellular defenses against ssRNA: phosphatase treatment, substituting cytidine...

...rendering the Cas9 non-functional when split but regaining functionality when the halves are reassociated...